Gateway 2011: Sensient Pharmaceutical Coating Systems
Sensient® Pharmaceutical Coating Systems is a global leader in superior coating systems, brand-defining color solutions, and enhanced product performance for the pharmaceutical and nutraceutical markets. A single source for complete coating and visual enhancement solutions, we’re committed to innovation not only in our superior products and solutions but also in our personalized, responsive service.
Sensient Pharmaceutical Coating Systems leads the industry in the development and manufacture of innovative coatings and colors for the pharmaceutical and nutraceutical industries. Our coatings, excipients, and imprint inks offer visual and functional attributes necessary for brand definition, product identification, and trademark protection. Please visit us at AAPS 2011 at Booth #1419.
Sensient Pharmaceutical Coating Systems
2515 N. Jefferson, St. Louis, MO 63106
Phone: 800.325.8110
E-mail: info@sensientpharma.com
URL: www.sensientpharma.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
